| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -91% |
| 3Y CAGR | +126% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +28% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,646.70 +19.10 (0.41%) | 21,168.16 | 28.79 | 5.04 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,838.20 +117.70 (4.33%) | 20,634.90 | 30.43 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,937.50 +69.50 (1.01%) | 17,175.63 | 101.26 | 19.68 | ||
Natco PharmaNATCOPHARM | ₹838.45 -4.80 (0.57%) | 15,100.75 | 13.19 | 1.64 |